Allergy Relieving Eye Drops Market - Growth, Trends, and Forecast (2020 - 2025)
|出版商||Mordor Intelligence LLP||商品編碼||921869|
|出版日期||內容資訊||英文 111 Pages
|全球過敏症狀緩和用眼科用藥市場:成長，趨勢，及預測(2020年∼2025年) Allergy Relieving Eye Drops Market - Growth, Trends, and Forecast (2020 - 2025)|
|出版日期: 2020年01月01日||內容資訊: 英文 111 Pages||
Eye Allergy has been increasing in recent years. According to a report by BioMed Research International 2017, the overall prevalence of ocular allergy among school children in Shanghai, China is about 28%. Also, it has been observed that around 15% to 20%of the US population suffers from an ocular allergy. This high prevalence of ocular allergy has increased the demand for allergy eye drops and hence, this factor has acted as a driving factor helping this market grow.
Furthermore, the increasing research and development in eye allergy medication have also brought new innovative medications to the market which are more effective than their predecessors. This factor has also helped this market grow. However, side effects from allergy relieving eye drops, including irritation, headache, and others, have been restraining the growth of this market.
An allergic reaction occurs when a person's immune system reacts to an allergen in the environment, either indoors or outdoors. An allergen is any substance that causes allergy symptoms in sensitive individuals. Allergy relieving eye drops are used to prevent and treat itching of the eyes caused by allergies.
In the report, a detailed analysis of the allergy relieving eye drops market is provided. The market is evaluated by collating revenues generated across segments, categorized by drug class, type, and geography.
Antihistamines are Expected to Register a High Growth Rate
Antihistamines block histamine release from histamine-1 receptors and are used to treat the symptoms of an allergic reaction such as edema (swelling), itch, inflammation (redness), and watery eyes.
Eye edema is a very common occurrence. It is primarily caused by Unhealthy cornea prior to surgery. Subsequently, any procedure within the eye (such as cataract, glaucoma or retinal surgery) can cause the cornea to fail and develop edema. As antihistamines effectively treat edema, the market is expected to increase in the forecast period.
North America is expected to dominate the market
North America includes the United States (US), Canada, and Mexico. The United States and Canada have developed healthcare systems and also spend huge amounts in research and development fo the same. As a result, most of the global treatments are available in this region.
According to a Yanqing Feng et al, published in BioMed Research International 2017, among the US households, 34% prevalence of Ocular Allergy symptoms were reported in children. This high prevalence has increased the demands for ocular allergy medications, which is helping the growth of the Allergy Relieving Eye Drops market.
The majority of the allergy relieving eye drops are being manufactured by the global key players. Market leaders with more funds for research and a better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing the emergence of some small players due to the rise of awareness. This has also helped the market growth.